期刊
CHEMICAL SOCIETY REVIEWS
卷 47, 期 18, 页码 6990-7005出版社
ROYAL SOC CHEMISTRY
DOI: 10.1039/c8cs00499d
关键词
-
资金
- Advion
- BBSRC
- CRUK
- EPSRC
- GlaxoSmithKline
- MRC
- SNF
- UCB
- GE Healthcare
- Academy of Finland
- Finnish centre of excellence in molecular imaging in cardiovascular and metabolic research
- CRUK [CS255/A16466]
- University of Caen
- Imanova
Radiolabelled (bio)molecules have advanced many areas of science from fundamental biology to human health including applications in molecular imaging and more generally nuclear medicine. Today, the field of radiochemistry is rapidly expanding, a trend resulting from the increasing demand for labelled molecules necessary for diagnosis and to accelerate pharmaceutical drug development. More often, the synthesis of labelled (bio)molecules employs a pre-functionalised precursor to allow for the chemoselective installation of a particular radioisotope-containing substituent. Among the array of precursors available, boron reagents occupy a prominent place because they are easy to handle, numerous possibilities exist for their preparation, and their reactivity has been well studied especially in cross-coupling chemistry. In this review, we discuss the value of boron-based precursors for the radiolabelling of (bio)molecules with the radionuclides carbon-11, fluorine-18, iodine-123, iodine-125 and iodine-131, and we illustrate how these radiosynthetic advances have opened the radiochemical space available for areas such as PET and SPECT imaging.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据